naloxone hydrochloride dihydrate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial AUST R: 309381Active ingredients:
naloxone hydrochloride dihydrate
Dosage form:
Spray, nasal
Sponsor:
Mundipharma Pty Ltd
Phone:
1800 188 009
|
From
10 Dec 2024
to
31 Dec 2025
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Unexpected increase in consumer demand
Management action:
Due to the ongoing increase in demand, limited supply is expected to continue until 31 December 2025. The TGA is in consultation with the sponsor to monitor supply. An unregistered product has been approved for supply under Section 19A. The approval holder, Link Medical Products Pty Ltd, can be contacted for details on supply on 1800 181 060.
|